ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Henrik Jönsson
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jönsson, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jönsson, H.
Related Collections
Right arrow Cerebral protection

Ann Thorac Surg 2006;82:56
© 2006 The Society of Thoracic Surgeons


Original article: Cardiovascular

Invited commentary

Henrik Jönsson, MD, PhD

Department of Cardiothoracic Surgery, Lund University Hospital, Lund, SE-221 85 Sweden

(Email: henrik.jonsson{at}med.lu.se).

This article addresses an important and very interesting topic (ie, the potential deleterious effects of retransfusion cardiotomy suction blood to the cardiopulmonary circulation) [1]. In a small material such as this study, S100B sampling is the end point that would yield the most interesting results. The authors have chosen to use only one time for sampling, and rather soon after the operation. The sampling after a couple of hours is known to be fraught with methodological problems, which the authors also point out. It would be interesting to see a couple of S100B samples between 6 and 24 hours. Lacking these data, it is difficult to draw any eligible conclusions from S100B levels in this series of patients.

Albeit the shortcomings of the study, such as small sample size and suboptimal timing of S100B sampling, the findings of the study raises some interesting thoughts. In the cell-saver group they had 3 patients with a history of stroke and none in the control group. In outcome they found no strokes in the cell-saver group but one in the control group. Although, not even close to any statistical significance, this finding provokes the interesting question as to whether removing unwanted substances such as cytokines, S100B, and lipid particles will decrease the risk of focal ischemic brain damage. It is well known that lipid particles from shed blood will end up in different organs of the body. The hypothesis that lipid particles could be a mechanism behind focal ischemic brain damage is very interesting, and will hopefully be addressed in studies with a larger cohort.


    References
 Top
 References
 

  1. Carrier M, Denault A, Lavoie J, Perrault LP. Randomized controlled trial of pericardial blood processing with a cell-saving device on neurologic markers in elderly patients undergoing coronary artery bypass graft surgery Ann Thorac Surg 2006;82:51-56.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Henrik Jönsson
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jönsson, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jönsson, H.
Related Collections
Right arrow Cerebral protection


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS